Investigation of Pump Compatibility of Fast-Acting Insulin Aspart in Subjects With Type 1 Diabetes

BACKGROUND: Ultra-fast-acting insulins, such as fast-acting insulin aspart (faster aspart), have pharmacokinetic properties that may be advantageous for patients using continuous subcutaneous insulin infusion (CSII), provided that they are compatible with and safe to use in CSII. METHODS: Randomized...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Diabetes Sci Technol
Egile Nagusiak: Zijlstra, Eric, Demissie, Marek, Graungaard, Tina, Heise, Tim, Nosek, Leszek, Bode, Bruce
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SAGE Publications 2017
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5761985/
https://ncbi.nlm.nih.gov/pubmed/28918652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1932296817730375
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak